Last updated at 28 Feb 2025 03:14 AM
Director
DIN: 08587852
Prafful Jain is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Individual Subscriber. They serve as a Director at ALLOZEN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08587852.Prafful Jain is currently involved in 3 different roles. Their most recent position is with MEDCHAIN PHARMA PRIVATE LIMITED as a Individual Subscriber. The first company Prafful Jain was appointed to as a director was ALLOZEN PHARMA PRIVATE LIMITED. Prafful Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Prafful Jain is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Individual Subscriber. They serve as a Director at ALLOZEN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08587852.Prafful Jain is currently involved in 3 different roles. Their most recent position is with MEDCHAIN PHARMA PRIVATE LIMITED as a Individual Subscriber. The first company Prafful Jain was appointed to as a director was ALLOZEN PHARMA PRIVATE LIMITED. Prafful Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ALLOZEN PHARMA PRIVATE LIMITED | Director | 16-Oct-2019 |
| ALLOZEN PHARMA PRIVATE LIMITED | Individual Promoter | 16-Oct-2019 |
| NEXAMED GLOBAL PRIVATE LIMITED | Director | 19-May-2023 |
| MEDCHAIN PHARMA PRIVATE LIMITED | Individual Subscriber | 13-Jan-2025 |